Selected article for: "acute respiratory and lymphoma patient"
Author: Baang, Ji Hoon; Smith, Christopher; Mirabelli, Carmen; Valesano, Andrew L; Manthei, David M; Bachman, Michael A; Wobus, Christiane E; Adams, Michael; Washer, Laraine; Martin, Emily T; Lauring, Adam S
Title: Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient
  • Cord-id: a4rgnn48
  • Document date: 2020_10_22
    • ID: a4rgnn48
    Snippet: We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis demonstrate ongoing replication of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for at least 119 days. The patient had 3 admissions related to COVID-19 over a 4-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms. The patient’s lack of seroconversion
    Document: We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis demonstrate ongoing replication of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for at least 119 days. The patient had 3 admissions related to COVID-19 over a 4-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms. The patient’s lack of seroconversion and prolonged course illustrate the importance of humoral immunity in resolving SARS-CoV-2 infection. This case highlights challenges in managing immunocompromised hosts, who may act as persistent shedders and sources of transmission.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acid testing: 1
    • absence presence and acute viral infection: 1, 2, 3
    • absence presence and admission day: 1, 2
    • absence presence and long period: 1, 2, 3, 4, 5
    • absence presence and lymphoma treatment: 1
    • acid testing and acute viral infection: 1, 2
    • acid testing and admission day: 1, 2, 3, 4
    • acid testing and long period: 1, 2
    • acute viral infection and admission day: 1, 2, 3
    • acute viral infection and long period: 1
    • additional case and admission day: 1
    • additional case and long period: 1, 2, 3
    • admission day and long period: 1, 2, 3, 4
    • admission day and lymphoma treatment: 1